BetterLife Pharma Inc. Files October 2024 6-K Report
Ticker: BETRF · Form: 6-K · Filed: Oct 15, 2024 · CIK: 1464165
Sentiment: neutral
Topics: 6-K, foreign-issuer, regulatory-filing
Related Tickers: BETRF
TL;DR
BetterLife Pharma (BETRF) filed its October 6-K, standard foreign issuer report. Nothing major disclosed.
AI Summary
BetterLife Pharma Inc. filed a Form 6-K on October 15, 2024, reporting for the month of October 2024. The company, formerly known as Pivot Pharmaceuticals Inc. and Neurokine Pharmaceuticals Inc., is based in Vancouver, BC, and operates in the Pharmaceutical Preparations sector. This filing is a routine report for foreign private issuers.
Why It Matters
This filing provides an update on BetterLife Pharma Inc.'s regulatory reporting status as a foreign private issuer, which is important for investors tracking their compliance and disclosures.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain significant new financial or operational information that would immediately impact the company's risk profile.
Key Players & Entities
- BetterLife Pharma Inc. (company) — Filer
- Pivot Pharmaceuticals Inc. (company) — Former Company Name
- Neurokine Pharmaceuticals Inc. (company) — Former Company Name
- October 15, 2024 (date) — Filing Date
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.
When was BetterLife Pharma Inc. previously known by other names?
BetterLife Pharma Inc. was formerly known as Pivot Pharmaceuticals Inc. (name change on 20150417) and Neurokine Pharmaceuticals Inc. (name change on 20090514).
What is BetterLife Pharma Inc.'s fiscal year end?
BetterLife Pharma Inc.'s fiscal year ends on January 31 (0131).
What is the SIC code for BetterLife Pharma Inc.?
The Standard Industrial Classification (SIC) code for BetterLife Pharma Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Does BetterLife Pharma Inc. file its annual reports under Form 20-F or 40-F?
BetterLife Pharma Inc. indicates it files annual reports under cover of Form 20-F.
Filing Stats: 345 words · 1 min read · ~1 pages · Grade level 14.9 · Accepted 2024-10-15 15:38:01
Filing Documents
- betrf_6k.htm (6-K) — 10KB
- betrf_ex991.htm (EX-99.1) — 6KB
- 0001477932-24-006432.txt ( ) — 18KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934 , the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. . BETTERLIFE PHARMA INC. Date: October 15, 2024 By: /s/ Moira Ong Name: Moira Ong Title: Chief Financial Officer 3